SCHEMBL1709086

SCHEMBL1709086

COc1cc(C(NC(=O)OC(C)(C)C)C(c2ccccc2)[N+](=O)[O-])ccc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 5/20 0.38
CTSS P25774 3/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 4/20 0.37
HPGD P15428 1/20 0.37
AAK1 Q2M2I8 3/20 0.36
GABRB1 P18505 1/20 0.36
GABRB2 P47870 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16254012 1.00 CTSK (0.38) CTSKCTSSALDH1A1GAAPKM
SCHEMBL1699073 0.88 CTSK (0.39) CTSKCTSSMEN1KMT2AMAPT
SCHEMBL16239371 0.87 ALDH1A1 (0.41) ALDH1A1GAAPKMMEN1KMT2A
SCHEMBL16239372 0.87 ALDH1A1 (0.41) ALDH1A1GAAPKMMEN1KMT2A
SCHEMBL16239369 0.87 ALDH1A1 (0.41) ALDH1A1GAAPKMMEN1KMT2A
SCHEMBL8221949 0.76 HPGD (0.50) CTSKCTSSALDH1A1GAAPKM
SCHEMBL18854495 0.76 HPGD (0.50) CTSKCTSSALDH1A1GAAPKM
SCHEMBL1282541 0.76 MEN1 (0.36) ALDH1A1GAAPKMMEN1KMT2A
SCHEMBL1282397 0.76 MEN1 (0.36) ALDH1A1GAAPKMMEN1KMT2A
SCHEMBL17302048 0.75 S1PR3 (0.43) CTSKCTSSALDH1A1MAPTGABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088915-A1 STEREOSELECTIVE METHODS, CATALYSTS AND INTERMEDIATES FOR THE SYNTHESIS OF (-)-NUTLIN-3 AND RELATED COMPOUNDS VANDERBILT UNIVERSITY 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088915-A1 STEREOSELECTIVE METHODS, CATALYSTS AND INTERMEDIATES FOR THE SYNTHESIS OF (-)-NUTLIN-3 AND RELATED COMPOUNDS NUTF2, MDM2, CIAPIN1 CTSK 2403/4885CTSS 1005/4885ALDH1A1 2092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.